deltatrials
Terminated PHASE1 INTERVENTIONAL 2-arm NCT04990219

A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis

Interventional, Randomized, Double-blind, Placebo-controlled, Parallel-group, Phase 1B Study Investigating the Effects of Lu AG06466 for the Treatment of Spasticity in Patients With Multiple Sclerosis

Sponsor: H. Lundbeck A/S

Conditions Multiple Sclerosis
Interventions Lu AG06466 Placebo
Updated 10 times since 2021 Last updated: Feb 1, 2023 Started: Sep 27, 2021 Primary completion: Jan 19, 2023 Completion: Jan 31, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The study was terminated for strategic reasons

Other terminated trials from H. Lundbeck A/S

See all terminations from H. Lundbeck A/S

Other Multiple Sclerosis trials with similar outcome

Browse all Multiple Sclerosis trials

A PHASE1 clinical study on Multiple Sclerosis, this trial is terminated or withdrawn. The trial is conducted by H. Lundbeck A/S and has accumulated 10 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Sep 2021 – ~Nov 2021 · 2 months · monthly snapshot~Nov 2021 – ~Jun 2022 · 7 months · monthly snapshotRecruiting~Jun 2022 – ~Sep 2022 · 3 months · monthly snapshot~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Jan 2023 · 2 months · monthly snapshot~Jan 2023 – ~Mar 2023 · 59 days · monthly snapshot~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 10 months · monthly snapshotTerminated

Change History

10 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE1

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  4. Mar 2023 — Jul 2024 [monthly]

    Terminated PHASE1

    Status: Active Not Recruiting → Terminated

  5. Jan 2023 — Mar 2023 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

▶ Show 5 earlier versions

  1. Nov 2022 — Jan 2023 [monthly]

    Recruiting PHASE1

  2. Sep 2022 — Nov 2022 [monthly]

    Recruiting PHASE1

  3. Jun 2022 — Sep 2022 [monthly]

    Recruiting PHASE1

  4. Nov 2021 — Jun 2022 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  5. Sep 2021 — Nov 2021 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • H. Lundbeck A/S
Data source: H. Lundbeck A/S

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations